These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33417081)

  • 1. Development of a Pediatric Mini-Tablet Formulation for Expedited Preclinical Studies.
    Lavan M; Wang X; McCain R; Jannasch A; Cooper B; Hostetler S; Byrn S; Knipp G
    AAPS PharmSciTech; 2021 Jan; 22(1):40. PubMed ID: 33417081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decoding the small size challenges of mini-tablets for enhanced dose flexibility and micro-dosing.
    Mitra B; Thool P; Meruva S; Aycinena JA; Li J; Patel J; Patel K; Agarwal A; Karki S; Bowen W
    Int J Pharm; 2020 Jan; 574():118905. PubMed ID: 31809860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Surfactants on Itraconazole-Hydroxypropyl Methylcellulose Acetate Succinate Solid Dispersion Prepared by Hot Melt Extrusion III: Tableting of Extrudates and Drug Release From Tablets.
    Solanki NG; Kathawala M; Serajuddin ATM
    J Pharm Sci; 2019 Dec; 108(12):3859-3869. PubMed ID: 31542437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
    Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
    AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Oral Flexible Tablet (OFT) Formulation for Pediatric and Geriatric Patients: a Novel Age-Appropriate Formulation Platform.
    Chandrasekaran P; Kandasamy R
    AAPS PharmSciTech; 2017 Aug; 18(6):1972-1986. PubMed ID: 27921260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of HPMC concentration on release of theophylline or hydrocortisone from extended release mini-tablets.
    Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2013 Aug; 39(8):1167-74. PubMed ID: 22540355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, in vitro, preclinical and clinical evaluations of once daily sustained release tablets of aceclofenac.
    Mutalik S; Naha A; Usha AN; Ranjith AK; Musmade P; Manoj K; Anju P; Prasanna S
    Arch Pharm Res; 2007 Feb; 30(2):222-34. PubMed ID: 17366745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Approach to Flurbiprofen Pulsatile Colonic Release: Formulation and Pharmacokinetics of Double-Compression-Coated Mini-Tablets.
    Vemula SK
    AAPS PharmSciTech; 2015 Dec; 16(6):1465-73. PubMed ID: 26017285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined site-specific release retardant mini-matrix tablets (C-SSRRMT) for extended oral delivery of dexketoprofen trometamol:
    Sweed NM; Basalious EB; Nour SA
    Drug Dev Ind Pharm; 2019 Nov; 45(11):1777-1787. PubMed ID: 31418598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of nilvadipine solid dispersion to tablet formulation and manufacturing using crospovidone and methylcellulose as dispersion carriers.
    Hirasawa N; Ishise S; Miyata H; Danjo K
    Chem Pharm Bull (Tokyo); 2004 Feb; 52(2):244-7. PubMed ID: 14758011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of mini-tablets as a flexible drug delivery tool.
    Mitra B; Chang J; Wu SJ; Wolfe CN; Ternik RL; Gunter TZ; Victor MC
    Int J Pharm; 2017 Jun; 525(1):149-159. PubMed ID: 28432019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tablet formulation and subsequent film coating on the supersaturated dissolution behavior of amorphous solid dispersions.
    Sakai T; Hirai D; Kimura SI; Iwao Y; Itai S
    Int J Pharm; 2018 Apr; 540(1-2):171-177. PubMed ID: 29447848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel tablet formulation of amorphous candesartan cilexetil solid dispersions involving P-gp inhibition for optimal drug delivery: in vitro and in vivo evaluation.
    Surampalli G; Nanjwade BK; Patil PA; Chilla R
    Drug Deliv; 2016 Sep; 23(7):2124-2138. PubMed ID: 25080228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and optimization of gastric floating sustained-release mini-tablets of alfuzosin hydrochloride based on a factorial design: in vitro/in vivo evaluation.
    Gong L; Yu M; Sun Y; Gao Y; An T; Zou M; Cheng G
    Drug Dev Ind Pharm; 2018 Dec; 44(12):1990-1999. PubMed ID: 30058391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hot Melt Extrusion: Development of an Amorphous Solid Dispersion for an Insoluble Drug from Mini-scale to Clinical Scale.
    Agrawal AM; Dudhedia MS; Zimny E
    AAPS PharmSciTech; 2016 Feb; 17(1):133-47. PubMed ID: 26729533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of manufacturing process variables on in vitro dissolution characteristics of extended-release tablets formulated with hydroxypropyl methylcellulose.
    Huang Y; Khanvilkar KH; Moore AD; Hilliard-Lott M
    Drug Dev Ind Pharm; 2003 Jan; 29(1):79-88. PubMed ID: 12602495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
    Indulkar AS; Lou X; Zhang GGZ; Taylor LS
    Mol Pharm; 2019 Mar; 16(3):1327-1339. PubMed ID: 30669846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amorphous solid dispersion of ibuprofen: A comparative study on the effect of solution based techniques.
    Ziaee A; O'Dea S; Howard-Hildige A; Padrela L; Potter C; Iqbal J; Albadarin AB; Walker G; O'Reilly EJ
    Int J Pharm; 2019 Dec; 572():118816. PubMed ID: 31678527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mini-tablets: a contemporary system for oral drug delivery in targeted patient groups.
    Aleksovski A; Dreu R; Gašperlin M; Planinšek O
    Expert Opin Drug Deliv; 2015 Jan; 12(1):65-84. PubMed ID: 25200881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of biorelevant in vitro assays for the assessment and optimization of ASD-based formulations for pediatric patients.
    Niessen J; López Mármol Á; Ismail R; Schiele JT; Rau K; Wahl A; Sauer K; Heinzerling O; Breitkreutz J; Koziolek M
    Eur J Pharm Biopharm; 2023 Apr; 185():13-27. PubMed ID: 36813089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.